MISSION THERAPEUTICS
Mission Therapeutics is a drug development company targeting the ubiquitin pathway for the treatment of kidney disease, neurodegenerative disease, rare mitochondrial diseases and fibrosis. The Company has built a leading platform for the discovery and development of first-in-class, small-molecule drugs that selectively target deubiquitylating enzymes (DUBs) – an emerging drug class that is attracting significant commercial interest in the area of protein homeostasis.
MISSION THERAPEUTICS
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2011-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.missiontherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
+44 (0)1223 607 340
Email Addresses:
[email protected]
Total Funding:
143.07 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Apple Mobile Web Clips Icon WordPress Wordpress Plugins Microsoft Exchange Online Office 365 Mail IPv6
Similar Organizations
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Michael J. Fox Foundation
Michael J. Fox Foundation investment in Grant - MISSION Therapeutics
Pfizer Venture Investments
Pfizer Venture Investments investment in Venture Round - MISSION Therapeutics
SR One
SR One investment in Venture Round - MISSION Therapeutics
IP Group
IP Group investment in Venture Round - MISSION Therapeutics
Schroder Adveq
Schroder Adveq investment in Venture Round - MISSION Therapeutics
Roche Venture Fund
Roche Venture Fund investment in Venture Round - MISSION Therapeutics
Sofinnova Partners
Sofinnova Partners investment in Venture Round - MISSION Therapeutics
Michael J. Fox Foundation
Michael J. Fox Foundation investment in Grant - MISSION Therapeutics
Woodford Investment Management
Woodford Investment Management investment in Series C - MISSION Therapeutics
Sofinnova Partners
Sofinnova Partners investment in Series C - MISSION Therapeutics
Official Site Inspections
http://www.missiontherapeutics.com Semrush global rank: 6.8 M Semrush visits lastest month: 782
- Host name: grapefruit.active-ns.com
- IP address: 84.18.207.60
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "MISSION Therapeutics"
Mission Therapeutics – Deubiquitylating enzymes: multiple drug ...
World-leading DUB platform translating scientific advances into transformative therapies. First-in-class small molecule DUB inhibitors developed in-house and with partners. Multiple in-house …See details»
About mission – Mission Therapeutics
Mission Therapeutics is a world leader in developing novel therapeutics which combat serious diseases including Parkinson’s Disease by enhancing mitophagy – the vital quality control process cells use to ensure dysfunctional …See details»
Science – Mission Therapeutics
Our team has the experience, expertise and determination to turn scientific advances in deubiquitylating enzymes (DUBs) into transformative therapies for serious illnesses including Parkinson’s Disease.See details»
MISSION Therapeutics - Crunchbase Company Profile …
MISSION Therapeutics develops therapies that enhance the removal of dysfunctional mitochondria to combat serious diseases. MISSION Therapeutics received $5.2 million for its potential Parkinson’s treatment. View contacts for …See details»
Mission Therapeutics - LinkedIn
Mission Therapeutics is a private, drug discovery and development company focused on selectively targeting deubiquitylating enzymes to treat diseases of high unmet need.See details»
Mission Therapeutics Awarded Follow-On Therapeutic …
Oct 12, 2021 · Mission Therapeutics is an early-stage drug development company targeting the ubiquitin pathway for the treatment of kidney disease, neurodegenerative disease, rare mitochondrial diseases and...See details»
Leveraging novel chemistry to inhibit previously …
Mission Therapeutics combines novel biology, proprietary chemistry, and bespoke screening assays to address a previously undruggable class of enzymes, deubiquitylating enzymes (DUBs).See details»
Mission Therapeutics - PitchBook
Operator of a pharmaceutical research and drug discovery company intended to facilitate the development of advanced medical treatments.See details»
Mission Therapeutics awarded $5.2m from The Michael …
Cambridge, UK – 02 July 2024 – Mission Therapeutics (“Mission” or the “Company”), a clinical-stage biotech developing first-in-class therapeutics targeting mitophagy, has been awarded $5.2 million from The Michael J. Fox …See details»
MISSION Therapeutics - VentureRadar
Website: http://www.missiontherapeutics.com. Develops novel therapeutics to enhance cell and organ health, focusing on mitophagy, to treat diseases like Parkinson's and Alzheimer's. …See details»
Mission Therapeutics Authorised to Initiate First Clinical …
Mar 31, 2022 · Mission Therapeutics is an early-stage drug development company targeting the ubiquitin pathway for the treatment of kidney disease, neurodegenerative disease, rare mitochondrial diseases and...See details»
Mission Therapeutics commences landmark trial of MTX325, a …
Mar 21, 2024 · Mission Therapeutics ("Mission" or the "Company"), a clinical-stage biotech developing first-in-class therapeutics targeting mitophagy, today announces the start of a …See details»
Mission Therapeutics - Nature Biotechnology
Mar 7, 2012 · Scientists who first validated synthetic lethality as a tumor-killing strategy have been buoyed by a cash injection for their new spinout Mission Therapeutics.See details»
Vision and Values – Mission Therapeutics
Our corporate culture, our vision and values unite our diverse workforce. Our vision is to transform the treatment of serious illnesses by harnessing our world class knowledge of disease …See details»
Mission Therapeutics raises £25.2 million to progress clinical ...
Mar 14, 2024 · Mission Therapeutics is a world leader in discovering and developing novel therapeutics which promote the removal of dysfunctional mitochondria, promoting cell health …See details»
Mission Therapeutics - Craft
Mission Therapeutics is a company specializing in deubiquitylating enzyme drug discovery and development. It offers a platform for the discovery and development of small-molecule drugs …See details»
Mission Therapeutics - Overview, News & Similar companies
Jan 2, 2023 · View Mission Therapeutics (www.missiontherapeutics.com) location in Cambridgeshire, United Kingdom , revenue, industry and description. Find related and similar …See details»
Mission Therapeutics raises £25.2 million to progress clinical ...
Cambridge, UK – March 14, 2024 – Mission Therapeutics (“Mission” or the “Company”), a clinical-stage biotech developing first-in-class therapeutics that enhance mitophagy to promote …See details»
MISSION Therapeutics Ltd. (MISSION Therapeutics Ltd.) - 药物管 …
More than a decade after a Nobel Prize was awarded for the discovery of the ubiquitin-proteasome system and clinical approval of proteasome and ubiquitin E3 ligase inhibitors, first …See details»
Press Releases - Mission Therapeutics
Jul 2, 2024 · Deubiquitylating enzymes: multiple drug opportunities across therapeutic areasSee details»